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Abstract Here we present data supporting the role of lipid
rafts in endothelial cells during leukocyte adhesion. Following
adhesion of THP-1 cells or antibody-mediated clustering, both
E-selectin and intercellular adhesion molecule-1 (ICAM-1) par-
titioned into the detergent-insoluble portion of the endothelial
cellular lysate. Sucrose gradient centrifugation revealed the par-
titioning of clustered E-selectin and ICAM-1 with the low-den-
sity fraction where they co-fractionated with src family kinases,
markers of lipid rafts. Depleting the plasma membrane of cho-
lesterol inhibited clustering of adhesion molecules following their
antibody-induced crosslinking and inhibited their association
with src kinases. Thus, our data suggest that E-selectin and
ICAM-1 associate with lipid rafts in human endothelial cells
following leukocyte adhesion. ( 2002 Published by Elsevier
Science B.V. on behalf of the Federation of European Biochem-
ical Societies.
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1. Introduction
Leukocyte recruitment involves leukocyte adhesion to the
endothelium, which is mediated by speci¢c adhesion molecules
such as E-selectin and intercellular adhesion molecule-1
(ICAM-1) expressed by the endothelial cells at sites of tissue
damage [1,2]. While the role of these adhesion molecules in
leukocyte recruitment is well established, the signals that are
transduced into endothelial cells following leukocyte adhesion
are not well characterized. Such signaling events could be
necessary to prime the endothelial cells for leukocyte trans-
migration by regulating endothelial barrier properties and cel-
lular contraction. Previously, we have shown that leukocyte
adhesion to endothelial cells results in the association of en-
dothelial cell adhesion molecules with at least one member of
the src family of non-receptor tyrosine kinases, and the phos-
phorylation of cortactin, an actin binding protein and sub-
strate of src family kinases [3]. Src family kinase activity
was necessary for adhesion molecule clustering at the site of
leukocyte contact. The mechanism whereby adhesion mole-
cules associate with these kinases, however, is unclear. It is
known that src family kinases such as Lck, Lyn, and Fyn,
because of their doubly acylated N-termini, preferentially as-
sociate with microdomains of the plasma membrane that con-
sist of tightly packed sphingolipids [4,5]. These microdomains,
termed ‘lipid rafts’, are enriched in cholesterol and are insolu-
ble in non-ionic detergents at 4‡C [6,7]. Lipid rafts are be-
lieved to be important in protein tra⁄cking and signal trans-
duction [8,9], and they would also provide a mechanism
whereby adhesion molecules could associate with src family
kinases. Here, we report that, following their engagement, the
endothelial cell adhesion molecules E-selectin and ICAM-1
become incorporated into the detergent-insoluble, low-density
portion of the cell lysate, consistent with their association with
lipid rafts. In addition, depletion of the plasma membrane of
cholesterol led to an inhibition of adhesion molecule cluster-
ing and a disruption of the adhesion molecule^src complex.
These results support a model whereby endothelial adhesion
molecules, upon adhesion to a leukocyte, will incorporate into
lipid rafts, which mediate their association with src family
kinases.
2. Materials and methods
2.1. Cells
Human umbilical vein endothelial cells (HUVECs) were isolated
from human umbilical cords as described previously [10]. Endothelial
cells were maintained in M199+15% iron-supplemented calf serum,
5% Nu serum, 1 U/ml penicillin/streptomycin, 1 U/ml fungizone,
1 U/ml heparin, and 10 Wl/ml endothelial cell growth supplement
(puri¢ed from bovine hypothalami as described previously [11]). HU-
VECs were routinely split 1:3 and were not used after passage 5. The
hybridoma cell lines and the THP-1 monocytic cell line [12] were
obtained from the American Type Culture Collection (Rockville,
MD, USA) and maintained in RPMI+10% fetal bovine serum
(FBS). THP-1 cells were ¢xed by washing twice with Hanks’ balanced
salt solution (HBSS, pH 7.4) followed by an incubation with 1% fresh
paraformaldehyde in phosphate-bu¡ered saline (PBS, pH 7.4) for
5 min at 37‡C. Fixation was stopped by adding 1 M ice-cold glycyl-
glycine. The cells were washed twice with PBS and incubated for 1 h
in RPMI+10% FBS at 37‡C to quench any remaining formaldehyde.
The cells were then washed twice in HBSS before use.
2.2. Antibodies and reagents
Anti-ICAM-1 and anti-E-selectin goat polyclonal antibodies were
purchased from RpD Systems (Minneapolis, MN, USA). M199,
HBSS, RPMI, penicillin/streptomycin, and fungizone were from Gib-
co. Serum was purchased from Summit Biotechnologies (Fort Collins,
CO, USA). Human recombinant tumor necrosis factor-K (TNFK) was
obtained from Calbiochem (La Jolla, CA, USA), and methyl-L-cyclo-
dextrin (BCD) was from Sigma.
Monoclonal antibodies to E-selectin (clone H18/7) and ICAM-1
(clone R6P5P) were puri¢ed from hybridoma supernatants using a
protein A/G column (Pierce) as per the manufacturer’s instructions.
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Antibody concentration was quantitated with the Dc Protein Assay
Kit (Bio-Rad). Each antibody was determined to be s 95% pure by
SDS^PAGE followed by Coomassie blue staining. Puri¢ed antibodies
were stored frozen at 320‡C in PBS with 0.1% bovine serum albumin.
Rabbit anti-src (SRC 2), a polyclonal antibody that detects multiple
members of the src kinase family, was from Santa Cruz Biotechnol-
ogies (Santa Cruz, CA, USA). Unconjugated rabbit anti-mouse anti-
bodies were purchased from ICN (Costa Mesa, CA, USA).
2.3. Detergent fractionation, sucrose gradient fractionation, and
Western blotting
The HUVEC monolayers were washed twice with HBSS, and 300 Wl
cold lysis bu¡er (50 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM
CaCl2, 1 mM MgCl2, 100 WM phenylmethylsulfonyl £uoride, 10 Wg/
ml leupeptin, 10 Wg/ml aprotinin, 2 mM Na3VO4, 10 mM NaPO4, and
10 mM NaF, containing either 1% or 0.1% Triton-X) was added to
the dish for 1 min on ice. The lysis bu¡er was then removed from the
dish and collected as the soluble portion of the lysate. The dish was
then washed twice with lysis bu¡er without Triton-X, and the remain-
ing insoluble cellular structures were scraped into 300 Wl lysis bu¡er
and collected as the insoluble portion. Both the soluble and insoluble
samples were diluted 1:1 in SDS^PAGE sample bu¡er. For sucrose
gradient fractionation, cells were lysed and scraped in 1 ml lysis bu¡er
containing 1% Triton-X. 1 ml of 80% sucrose in lysis bu¡er was added
to the lysates to achieve a ¢nal concentration of 40% sucrose. The
samples were placed at the bottom of a centrifuge tube, and a dis-
continuous gradient was achieved by layering 4 ml of 30% sucrose
above the sample followed by 4 ml of 5% sucrose. The gradients were
centrifuged in a Beckman SW-41 rotor at 31 000 rpm for 18 h at 4‡C.
Samples were taken from the top of the gradient, and proteins were
precipitated by the addition of cold trichloroacetic acid to a ¢nal
concentration of 10%. The pellets were washed twice with cold etha-
nol/acetone (1:1) and resuspended in 200 Wl SDS^PAGE sample bu¡-
er.
Samples were separated on a 7.5% polyacrylamide gel, and proteins
were transferred to nitrocellulose membranes and probed with anti-E-
selectin, anti-ICAM-1, or anti-src antibodies. Bound horseradish per-
oxidase-conjugated secondary antibodies were detected using a chem-
iluminescent substrate (Santa Cruz).
2.4. Immuno£uorescence microscopy
HUVECs were grown on ¢bronectin-coated glass coverslips until
con£uent and treated for 4 h with TNFK. Adhesion molecules were
clustered as above, using a £uorescein-conjugated secondary antibody
(Jackson Laboratories). The coverslips were then washed twice with
HBSS and then ¢xed with 3.7% formaldehyde. After three additional
washes with PBS, the coverslips were mounted on glass microscope
slides and examined under a £uorescence microscope. Photographs
were taken of the £uorescent images using a Nikon FX-35a camera.
2.5. Bead assay
Paramagnetic beads (Dynal, Oslo, Norway) were coated with a
monoclonal antibody against either E-selectin or ICAM-1 and were
allowed to adhere to TNFK-treated HUVECs for 15 min at 37‡C. The
cells were then washed twice with HBSS and lysed with lysis bu¡er
containing 1% Triton-X. The beads were separated from the remain-
ing cell lysate by a side-pull magnetic system (Dynal) washed three
times with lysis bu¡er. The beads were resuspended in 50 Wl SDS^
PAGE sample bu¡er and analyzed by Western blotting as above.
3. Results
3.1. E-selectin and ICAM-1 partition into the detergent-
insoluble portion of the cell lysate following engagement
A hallmark characteristic of lipid rafts is their resistance to
solubilization by non-ionic detergents at 4‡C [7]. Both E-se-
lectin and ICAM-1 were present in the 0.1% Triton-X-soluble
portion of lysates from TNFK-treated endothelial cells as de-
tected by Western blot analysis (Fig. 1, lane 1). A substantial
amount of ICAM-1 was present in the insoluble portion of
the lysate (Fig. 1, lane 2, bottom panel), indicating that
ICAM-1 may constitutively associate with lipid rafts or cyto-
skeletal proteins. Adhesion of THP-1 cells to the endothelial
cells prior to cellular lysis caused both E-selectin and ICAM-1
to become insoluble in 0.1% Triton-X (Fig. 1, lanes 3 and 4).
To speci¢cally engage either E-selectin or ICAM-1, monoclo-
nal antibodies directed against these proteins were allowed to
bind to TNFK-pretreated endothelial cells, followed by cross-
linking with a polyclonal secondary antibody to cluster the
adhesion molecules. The cells were lysed with 1% Triton-X
and the detergent-soluble and detergent-insoluble portions of
the lysates were analyzed by Western blotting for E-selectin
and ICAM-1 as above. In 1% Triton-X, both E-selectin and
ICAM-1 were primarily in the detergent-soluble portion of the
lysate (Fig. 2, lanes 1 and 2). However, following clustering
with antibodies, E-selectin and ICAM-1 partitioned into the
detergent-insoluble portion of the lysate (Fig. 2, lanes 3 and
4). This was not inhibited by cytochalasin B, even though
cytochalasin disrupted the actin cytoskeleton as determined
by £uorescent microscopy of endothelial cells stained with
phalloidin (data not shown). These data suggest that, upon
their engagement, both E-selectin and ICAM-1 associate with
detergent-insoluble structures other than the actin cytoskele-
ton in endothelial cells.
3.2. E-selectin and ICAM-1 fractionate into the low-density
portion of the cell lysates following engagement
To determine if endothelial cell adhesion molecules become
associated with detergent-insoluble portions of the plasma
membrane (‘lipid rafts’) following engagement, endothelial
cell lysates were fractionated by sucrose density gradient cen-
trifugation and fractions were analyzed by SDS^PAGE and
Western blotting. In TNFK-treated endothelial cells, both
E-selectin and ICAM-1 were primarily in the detergent-solu-
ble, high-density (40% sucrose) portion of the cell lysate (Fig.
3A). The blot was stripped and reprobed for src family
kinases as markers for lipid rafts, using a polyclonal antibody
that reacts with members of the src family, including c-Src,
Yes, and Fyn, which were predominantly detected in the raft
portion of the gradient (Fig. 3A, bottom). Following adhesion
molecule clustering with antibodies, E-selectin (Fig. 3B) and
ICAM-1 (Fig. 3C) both shifted into the low-density fraction
of the gradient, consistent with the association of these mol-
ecules with lipid rafts following adhesion molecule engage-
Fig. 1. E-selectin and ICAM-1 partition into the detergent-insoluble
fraction following THP-1 cell adhesion. THP-1 cells were allowed to
adhere to activated HUVECs and the cells were lysed as in Section
2. The detergent-soluble (S) and -insoluble (I) fractions of the cell
lysate were analyzed by Western blotting for E-selectin (top) or
ICAM-1 (bottom).
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ment. Src family kinases were predominantly maintained in
the lipid raft fraction regardless of adhesion molecule cluster-
ing (Fig. 3B,C, bottom panels). These results suggest that,
upon engagement, E-selectin and ICAM-1 are incorporated
into lipid rafts where they can associate with src family ki-
nases.
3.3. Membrane cholesterol is required for adhesion molecule
clustering and association with src family kinases
Clustering E-selectin (data not shown) and ICAM-1 (Fig.
4A) with a £uorescently labeled secondary antibody allowed
visualization of the adhesion molecule clusters, apparent as
punctate markings on the surface of endothelial cells (Fig.
4A, right panel). To determine if these punctate structures
represented lipid rafts, we treated endothelial cells with the
cholesterol-sequestering drug BCD prior to antibody-medi-
ated clustering of adhesion molecules. Plasma membrane de-
pletion of cholesterol resulted in an inhibition of clustering as
determined by £uorescence microscopy (Fig. 4B, right panels),
suggesting that cholesterol is required for this clustering event
and further implying an active role for lipid rafts in the clus-
tering of adhesion molecules.
We previously showed that at least one member of the src
family of non-receptor tyrosine kinases is associated with en-
gaged adhesion molecules in endothelial cells [3]. To deter-
mine if lipid rafts were required for this association, TNFK-
treated endothelial cells were incubated with BCD prior to
addition of beads coated with an antibody against E-selectin
or ICAM-1. The beads were allowed to adhere to the endo-
thelial cells, mimicking leukocyte adhesion. The cells were
then lysed and proteins bound to the beads were analyzed
by SDS^PAGE and Western blotting. BCD did not signi¢-
cantly inhibit binding of the beads to E-selectin and ICAM-1
(Fig. 5, top and middle panels). However, BCD did inhibit the
association of src family kinases with these molecules (Fig. 5,
bottom panel). This suggests that lipid rafts mediate the asso-
ciation between engaged adhesion molecules and src family
kinases.
4. Discussion
Tyrosine phosphorylation is known to play an important
role in cell adhesion. Phosphorylation of focal adhesion pro-
teins accompanies cellular adhesion to the extracellular ma-
trix, and tyrosine phosphorylation has also been implicated in
the regulation of cytoskeletal rearrangements [13,14]. Thus, it
is not surprising that src family kinases are activated following
E-selectin and ICAM-1 engagement [3,15]. However, exactly
how these adhesion molecules ^ which have very little homol-
ogy to each other ^ become associated with these kinases was
unresolved. Here, we show that both E-selectin and ICAM-1
become incorporated into lipid rafts upon engagement where
they co-fractionate with src family kinases in a sucrose gra-
dient. This would provide a mechanism whereby these adhe-
Fig. 2. Adhesion molecule partitioning into the insoluble fraction
following antibody-induced clustering is not inhibited by cytochala-
sin B. Either E-selectin (top) or ICAM-1 (bottom) was clustered on
HUVECs by antibody crosslinking (X-Link) in the absence or pres-
ence of cytochalasin B (Cyt.). The cellular lysate was separated into
detergent-soluble (S) or -insoluble (I) fractions and analyzed by
Western blotting for E-selectin (top) or ICAM-1 (bottom).
Fig. 3. Endothelial adhesion molecule partition with lipid rafts fol-
lowing antibody-mediated clustering. HUVEC whole cell lysates
were fractionated in a discontinuous sucrose gradient by equilibrium
centrifugation. Fractions were taken from the top of the gradient
and the pellet (P) and analyzed by Western blot. A: HUVEC ly-
sates with unclustered adhesion molecules. Sucrose gradient frac-
tions were analyzed by Western blotting for ICAM-1 (top), E-selec-
tin (middle), or src family kinases (bottom). ICAM-1 (B) or
E-selectin (C) was clustered by antibodies prior to cell lysis and
equilibrium centrifugation, and samples were analyzed by Western
blotting for ICAM-1 (B, top), E-selectin (C, top), or src family ki-
nases (A and B, bottom). The IgG band in B and C represents the
heavy chain of the rabbit polyclonal antibody that was used to clus-
ter the adhesion molecules.
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sion molecules are coupled to a tyrosine kinase. Exactly how
these kinases become activated remains unknown, although it
has been shown that clustering of lipid rafts in cells is su⁄-
cient to activate src family kinases such as Lck [16,17]. Thus,
adhesion molecule clustering as a result of leukocyte adhesion
could also induce the clustering of lipid rafts, resulting in src
family kinase activation and cortactin phosphorylation. Phos-
phorylated cortactin is known to bind to the SH2 domains of
several sca¡olding proteins and kinases, including c-src [18].
The SH2 domains of other, raft-associated src family mem-
bers were not examined, however it is likely that they also
would then bind to phosphorylated cortactin, resulting in
linkage of the raft to the actin cytoskeleton and further adhe-
sion molecule clustering.
Another possible function of lipid raft incorporation would
be the maintenance of the adhesion molecules as a cluster.
The lipid rafts would serve to restrict lateral di¡usion of the
adhesion molecules in the plasma membrane once they have
been incorporated into the cluster, thereby maintaining a high
localized concentration of the adhesion molecule at the site of
adhesion. This would result in a higher a⁄nity for the leuko-
cyte due to the increased number of adhesion molecules at
that site. A similar role has been proposed for lipid rafts in
B cells during antigen presentation, where rafts would serve to
concentrate the MHC molecule in patches along with its
bound peptide on the surface of the cell [19]. In endothelial
cells, incorporation into lipid rafts could represent the initial
step in the larger-scale clustering of adhesion molecules, an
event that is necessary for e⁄cient leukocyte adhesion.
One issue that remains unresolved is the precise mechanism
whereby E-selectin and ICAM-1 become incorporated into
lipid rafts. Several other transmembrane proteins have been
reported to associate with lipid rafts; however, a speci¢c ami-
no acid sequence that mediates this association has yet to be
identi¢ed [19^22]. A strong possibility is that these transmem-
brane proteins have a basal a⁄nity for lipid rafts that is sub-
stantially increased upon clustering [23]. This notion is sup-
ported by the data showing the di¡erences in the amount of
unclustered E-selectin and ICAM-1 in the 0.1% Triton-X-in-
soluble portion of the cellular lysate (Fig. 1). This may be due
to di¡erences in the amino acid sequence of their transmem-
brane domains.
Fig. 4. Cholesterol depletion inhibits adhesion molecule clustering. A: ICAM-1 staining pattern on cells treated with the primary antibody (1‡,
left panel) and both the primary and the secondary crosslinking antibodies (1‡ 2‡, right panel). Magni¢cation, 400U. B: E-selectin (top panels)
or ICAM-1 (bottom panels) were treated with a primary monoclonal antibody only (1‡), or the primary antibody followed by an FITC-conju-
gated secondary antibody (1‡ 2‡), either in the absence or in the presence of 10 mM BCD. Magni¢cation, 200U.
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The results reported here provide a mechanism that links
endothelial cell adhesion molecules to mediators of signal
transduction. Lipid rafts may thus represent an additional
target for therapies designed to attenuate leukocyte recruit-
ment in in£ammatory diseases.
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Fig. 5. The association of src family kinases with adhesion mole-
cules requires cholesterol. Beads coated with either E-selectin (lanes
1and 2) or ICAM-1 (lanes 3 and 4) were allowed to adhere to
TNFK-activated HUVECs in the presence (+) or absence (3) of 10
mM BCD. The beads were isolated and bound proteins were ana-
lyzed by Western blotting for ICAM-1 (top panel), E-selectin (mid-
dle panel), or src family kinases (bottom panel).
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